Business
genedrive plc (GDR): Western market progress bu...
genedrive plc (GDR): Western market progress bu....
About this update from Genedrive Plc
[{"type":"text","content":"\n \n\n\nHardman & Co Research\n\n\n\nHardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult05-Feb-2020 / 07:15 GMT/BST\n\n\nHardman & Co Research: Western market progress but developing markets difficult\n\nGenedrive plc (GDR) is a commercial-stage biotech focused on point-of-care molecular diagnostics. Its Genedrive(R) molecular diagnostic platform offers low-cost, simple-to-use devices for highly sensitive and specific testing. The rapid analysis of samples aids real-time decision-making, whether in clinical, public health or biothreat applications. GDR is developing a portfolio of assays for the Genedrive device, with its hepatitis C virus (HCV) and biothreat assays already on the market. The HCV diagnostics market is proving challenging due to a lack of access to HCV drugs, but biothreat revenue should support GDR in fiscal 2020.\n\nPlease click on the link below for the full report:\n\nhttps://www.hardmanandco.com/research/corporate-research/western-market-progress-but-developing-markets-difficult/\n\nIf you are interested in meeting the company, you can register your interest by clicking on the above link\n\n\n To contact us:\n\n Hardman & Co35 New Broad StreetLondonEC2M 1NH\n\n www.hardmanandco.com\n\n Follow us on Twitter @HardmanandCo\n \n \n Contact:\n\n Dr Martin Hall\n\n Dr Dorothea Hill\n\n Dr Gregoire Pave+44 20 7194 7622\n \n \n  \n\n [email protected]@[email protected] \n \n Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.\n\nAbout Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case. \n\nHardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital M...